ticlopidine has been researched along with Hyperpigmentation in 1 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Hyperpigmentation: Excessive pigmentation of the skin, usually as a result of increased epidermal or dermal melanin pigmentation, hypermelanosis. Hyperpigmentation can be localized or generalized. The condition may arise from exposure to light, chemicals or other substances, or from a primary metabolic imbalance.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liebschutz, S | 1 |
| Quéré, I | 1 |
| Lukasik, E | 1 |
| Dereure, O | 1 |
| Rondes, J | 1 |
| Janbon, C | 1 |
1 other study available for ticlopidine and Hyperpigmentation
| Article | Year |
|---|---|
[Hyperalgesic malleolar ulcer: recovery on the withdrawal of hydroxyurea].
Topics: Ankle; Enzyme Inhibitors; Female; Humans; Hydroxyurea; Hyperalgesia; Hyperpigmentation; Leg Ulcer; M | 1998 |